Skip to main content

Market Overview

18 Biggest Mid-Day Gainers For Tuesday

  • Benitec Biopharma Ltd (ADR) (NASDAQ: BNTC) shares jumped 64.4 percent to $5.03. Benitec Biopharma disclosed that the key pre-clinical data on oculopharyngeal muscular dystrophy has been published in Nature Communications.
  • General Communication, Inc. (NASDAQ: GNCMA) shares climbed 60 percent to $32.90 after Liberty Interactive Corporation (NASDAQ: LVNTA) announced plans to acquire General Communication for $1.12 billion.
  • Paratek Pharmaceuticals Inc (NASDAQ: PRTK) shares surged 29 percent to $24.00 after the company reported Phase 3 study of omadacycline in community-acquired bacterial pneumonia. The company disclosed that the study met all primary and secondary endpoints.
  • Conn's Inc (NASDAQ: CONN) shares surged 26 percent to $10.65 after the company reported better-than-expected earnings for its fourth quarter.
  • New Concept Energy, Inc. (NYSE: GBR) climbed 23 percent to $2.14. New Concept Energy reported Q4 earnings of $0.32 per share.
  • Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) gained 22 percent to $3.11.
  • Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) surged 16.4 percent to $4.17 as the company disclosed that it has been awarded U.S. patent for TSC as therapeutic in 5 hypoxia-related indications.
  • AmTrust Financial Services Inc (NASDAQ: AFSI) shares gained 16.4 percent to $21.28 after the company reported that it has filed 10-K with restated 2014 and 2015 financial statements.
  • Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) jumped 14.2 percent to $7.33 after surging 87.72 percent on Monday. Cyclacel issued a press release over the weekend which detailed a presentation from independent investigators. The investigation highlighted the therapeutic potential of Cyclacel's CYC065 therapy for the treatment of cancer. Specifically, the data found that CYC065 substantially inhibited growth, triggered apoptosis, and induced anaphase catastrophe in murine and human lung cancer cells with known high metastatic potential.
  • Staples, Inc. (NASDAQ: SPLS) rose 13.3 percent to $9.81. Dow Jones reported that Staples is exploring a possible sale of the company and is in early talks with buyout firms.
  • Onconova Therapeutics Inc (NASDAQ: ONTX) shares gained 11.9 percent to $3.37 after the company disclosed positive pre-clinical results for its cancer drugs.
  • MSG Networks Inc (NYSE: MSGN) rose 7.6 percent to $24.65. James Dolan’s MSG Networks is sounding out suitors, several sources told The Post.
  • TTM Technologies, Inc. (NASDAQ: TTMI) climbed 6.2 percent to $16.70. JP Morgan upgraded TTM Technologies from Neutral to Overweight.
  • ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) shares gained 5.8 percent to $1.88 after the company issued new insights into the mechanism of action of its hepatitis B virus-optimized cyclophilin inhibitor CRV431.
  • RedHill Biopharma Ltd - ADR (NASDAQ: RDHL) rose 5.1 percent to $10.05 after the company disclosed that it has received Orphan Drug designation for YELIVA.
  • TherapeuticsMD Inc (NYSE: TXMD) shares rose 4.4 percent to $7.74. TherapeuticsMD presented positive Phase 3 data in two presentations for TX-001HR at ENDO 2017.
  • Cirrus Logic, Inc. (NASDAQ: CRUS) gained 4 percent to $62.86. Pacific Crest upgraded Cirrus Logic from Sector Weight to Overweight.
  • Acadia Healthcare Company Inc (NASDAQ: ACHC) rose 3.2 percent to $44.22. Acadia Healthcare will replace Joy Global Inc. (NYSE: JOY) in the S&P MidCap 400 on April 6.

Related Articles (AFSI + ACHC)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Analyst Ratings Movers

Latest Ratings

OKTADeutsche BankMaintains270.0
AGCODeutsche BankMaintains145.0
SHAKDeutsche BankMaintains107.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at